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ABSTR ACT: African-born immigrants comprise one of the fastest growing populations in the U.S., nearly doubling its population size in recent years. 
However, it is also one of the most underrepresented groups in health-care research, especially research focused on gynecologic and breast malignancies. 
While the opportunity exists for access to an advanced health-care system, as immigrants migrate to the U.S., they encounter the same health-care inequali-
ties that are faced by the native-born population based on ethnicity and social class, potentiated by limitations of health literacy and lack of familiarity with 
U.S. health systems. Given the continued influx of African-born immigrants in the U.S., we sought to understand the representation of this population in 
cervical and breast cancer research, recognizing the population’s high risk for these diseases at baseline while residing in their native countries. We deter-
mined that there is limited research in these diseases that disproportionately affect them; yet, there are identifiable and potentially modifiable factors that 
contribute to this paucity of evidence. This clinical commentary seeks to underscore the clear lack of research available involving African-born immigrants 
with respect to gynecologic and breast malignancies in the existing literature, demonstrate the need for more robust research in this population, and provide 
fundamental insights into barriers and solutions critical to the continued health of this growing population.
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Introduction
The inequalities in access to health care for different ethnicities 
and social classes have been well documented. The unfortunate 
existence of these inequities affects one of the most vulnerable 
populations: immigrants. A vulnerable population is defined 
as a group at increased risk for poor physical, psychological, 
and social health outcomes and inadequate health care,1 which 
may apply to all immigrants, regardless of immigration sta-
tus. According to estimates from the 2012 American Com-
munity Survey, the U.S. immigrant population is just under 
15% of the total U.S. population, with growth between 2011 
and 2012 of almost one half of a million people.2 Contrib-
uting to the influx of immigrants are the U.S. policies that 
provide “refuge to persons who have been persecuted or have 
a well-founded fear of persecution”, through the U.S. refugee 
and asylum programs.3 The population admitted in the U.S. 
through its programs is largely a reproductive-age population, 
which makes it imperative to have a working understanding 
of outcomes in their reproductive health, including cancers of 
the reproductive organs.
In the U.S., African-born immigrants are among the 
fastest growing immigrant populations compared with 
other major groups, with a near doubling of its population 
size between 2000 and 2012 to approximately 1.6 million 
people according to the U.S. Census Bureau.4 Also, accord-
ing to the U.S. Census Bureau, in their 2008–2012 Ameri-
can Community Survey, of the 1.6 million foreign-born 
immigrants from Africa in the U.S., 36% were from Western 
Africa, 29% were from Eastern Africa, and 17% were from 
Northern Africa, followed by Southern Africa (5%), Middle 
Africa (5%), and other parts of Africa (7%).5 When consider-
ing these regions with the greatest influx, breast and cervi-
cal cancer comprise the top two contributors to the cancer 
incidence and mortality burden, affecting women in these 
resource-limited countries.6
Scope of the problem. Despite the rapid growth in 
the African-born immigrant population, research involv-
ing their health-related issues has been lacking. The limited 
research that has been conducted involving this population 
has largely focused on infectious diseases, such as human 
immunodeficiency virus (HIV) and tuberculosis (TB), while 
other important chronic diseases, such as screening for the 
development of malignancies, goes unstudied.7 The projec-
tions for cancer cases in Africa are expected to nearly double 
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to 1.28 million new cancer cases and 970,000 cancer deaths 
by 2030, simply due to the aging and growth of the popu-
lation.6,8 Over half a million (527,600) new cases of cervical 
cancer occur annually, and almost half of the deaths related 
to cervical cancer (254,374) were in women in less-developed 
countries.8,9 Of those deaths, almost 25% (60,100) occurred 
in Africa.9,10
Cervix and breast cancer top the list of leading cancers 
in women in Africa.6 There is, however, significant varia-
tion in disease burden, with “the highest incidence of HPV 
infection and cervical cancer found in Eastern and Western 
Africa”,11 which from where a significant proportion of the 
African-born immigrants have come to the U.S. in recent 
years (Table 1). Access to preventative health measures and 
improved therapeutic options for cancer care should be easily 
obtainable and its utilization encouraged in the United States 
for this population. Although the opportunity exists for access 
to an advanced health-care system, as immigrants migrate to 
the U.S., they encounter the same health-care inequalities 
that are faced by the native-born population based on ethnic-
ity and social class. An understanding of contributors to these 
health inequities is necessary to positively impact the health 
of this population.12
African-Born Immigrants and Barriers to Health
Access to health care. In a study of barriers to access to 
health care for sub-Saharan African refugees in Australia and 
the UK, it was identified that language barriers, literacy and 
educational deficiencies, lack of transportation, and limited 
understanding of the risks of their diseases disadvantaged 
families in access to care (Table 2).13,14 Additionally, this 
study of African immigrants in Australia highlighted that 
unemployment, poverty, and former negative experiences with 
health-care services in their home countries potentially served 
as a detractor from seeking health care in their newly settled 
country.14
In the U.S., studies focusing on cancer-specific health-
seeking behaviors and access to cancer services in African-
born female immigrants are limited and utilize small sample 
sizes and homogenous African populations. A systematic 
review of U.S. studies showed that barriers to screening for 
breast cancer echoed views seen in other countries of barriers 
to access to health care and also identified some new notions 
not previously discussed: barriers including “shame, modesty, 
and fear about screening procedures”.7 Using qualitative data, 
this study also highlights limited knowledge and familiar-
ity with cervical cancer and screening as important barriers 
to adherence to screening recommendations, in addition to 
beliefs of cervical cancer being “the will of God or a curse.”7 
Additionally, if female circumcision had been performed, a 
custom most commonly practiced in the western, eastern, 
and northeastern regions of Africa,15 there was anticipa-
tion of embarrassment by practitioners unfamiliar with the 
practice,7 leading to poor screening behaviors in women from 
these regions.
Involvement in health-care research. Understanding 
the health-seeking behaviors of the African-born immigrant 
population can largely be accomplished through quality 
research. Racial and ethnic minority participation in clinical 
research is paramount, and benefits such as “generalizability of 
research findings, equity in provision of health care, and accu-
racy of ethnicity-specific subgroup analyses” have been well 
established.16 When considering cancer care research, more 
than a third of the U.S. population comprises racial and ethnic 
minorities, but enrollment in the National Cancer Institute’s 
publicly funded cancer clinical trials revealed that less than 
Table 1. african-born population composition in the U.s. and breast and cervical cancer incidence.
REGIONAL AND COUNTRY-SPECIFIC DATA 
WITH LARGEST AFRICAN-BORN POPULATION 
IN U.S. BETWEEN 2008–2012 (PERCENTAGE OF 
AFRICAN-BORN IMMIGRANT POPULATION)
BREAST CANCER 
INCIDENCE, 2012 (PER 
100,000 WOMEN/YEAR)a,b
CERVICAL CANCER 
INCIDENCE, 2012 (PER 
100,000 WOMEN/YEAR)a,c
HUMAN PAPILLOMA VIRUS 
(HPV) PREVALENCEd
Western Africa (36%) 38.6 29.3 21.0
nigeria 50.4 29.0 27.5
ghana 25.6 35.4 *
Eastern Africa (29%) 30.4 42.7 36.0
ethiopia 41.8 26.4 *
Kenya 38.3 40.1 34.1
somalia 40.6 33.4 *
Northern Africa (17%) 43.2 6.6 29.1
egypt 49.5 2.3 6.8
United States 92.9 6.6 10.6
Notes: aage-standardized incidence rates (asR) of cervical cancer in regions of africa (estimations for 2012). bgloBoCan 2012 data. ciCo information Centre 
on hPV and Cancer (hPV information Centre) 2016. diCo information Centre on hPV and Cancer (hPV information Centre) 2016; data available through 2014; 
prevalence averaged on available data in women under the age of 65 years. *data not available.
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Table 2. Barriers to utilization of breast and cervical cancer preventative and treatment services in african-born immigrants.a
CLASSIFICATION PROBLEM POTENTIAL SOLUTION(S)
Socioeconomic
Poverty/lack of resources legal status is a major determinant of immi-
grants’ access to social services and jobs 
with benefits
Difficulty coordinating travel to appointments
gateway programs upon entering the U.s. to 
navigate legal system
increase resources/social programming avail-
able to immigrants
lack of insurance/economic 
support
immigrants have lower rates of health insurance 
coverage than U.s.-born populations; some 
differences based on immigration status, time in 
the U.s., and country of origin
increase awareness of health programming 
and free screening/healthcare opportunities 
in communities
access to healthcare and treatment 
bias
lack of knowledge about navigating the health 
system
Community liaisons within healthcare system
Cultural
Practices/beliefs (religious, spiritual 
or other)
limited number of providers who were famil-
iar with their cultural beliefs and/or practices; 
lack of open communication about cancer in 
communities
Cultural competency training in public facilities; 
CMe programs for clinical staff; provider pair-
ing or immigrant-health designated providers; 
social workers available; support groups and 
community-based education programs
gender-based concerns issues of modesty
social standing in households; beliefs of 
husbands/males about cancer/women’s health 
issues
Female practitioner provision
education of male community leaders; male 
community health workers providing education 
to other males
Education/health literacy
differences in health knowledge 
and practice
only visit healthcare provider when symptoms 
are present; cancer as a curse
Community health educators from communities; 
support groups
language barriers limited materials in their native language; 
interpreters unavailable or with limited medical 
knowledge
increase resources that are culturally and lin-
guistically sensitive; increase pool of certified 
interpreters and ensure medical interpretive skills
level of education overall, immigrants are less likely than U.s.-
born populations to have graduated from high 
school; although variations exist
offer educational services through community 
and use easy-to-understand language and edu-
cational materials
Psychosocial
Migration and immigration experi-
ences including acculturative stress
Competing priorities (work, school, family) social work and other support programs; 
evening/weekend medical services
Mistrust and other attitudes issues of privacy
issues related to trauma or assault
Mental health services available with specific 
competencies in immigrant health concerns
Perceived discrimination distrust of physicians and government facilities Community liaisons for healthcare system
note: aBased on extrapolated themes from studies utilized within this commentary.
18% of participants represented these groups,17 and there is no 
clear delineation of how many of those participants represent 
immigrant populations.
Various perceptions and behaviors of both the research-
ers and potential participants have been suggested to result 
in limited involvement of minority groups in research stud-
ies. Poor communication by researchers about important 
aspects of health-related trials, potentiated by the lack of 
knowledge about cultural differences among ethnic minori-
ties, has been indicated as a barrier to participation in 
research trials by minorities (Table 3). Furthermore, “psy-
chosocial issues” such as mistrust, fear, and lack of con-
fidence in the research process, in addition to logistical 
concerns including childcare, schedule conflicts, lack of 
transportation, and appropriate support, to research-related 
factors such as lengthy consent documents and lack of ade-
quate information about clinical research hinder racial and 
ethnic minority participation.17
In a study of African-born immigrant community 
leaders and views on African immigrants’ participation in 
genomic research, the study cited “a legacy of colonial mis-
treatment and exploitation by Western researchers in their 
home countries in sub-Saharan Africa” as a significant hin-
drance to participation.18 A “central dilemma for partici-
pants” was the conflict between responsibilities to protect 
their people from harm and finding solutions for future 
African generations.18 An understanding of the behaviors 
impacting cancer screening, treatment, and follow-up among 
African-born female immigrants may help to develop impor-
tant targeted interventions, and this understanding can best 
be achieved through thoughtful, inclusive, and culturally 
sensitive research targeted to this population (Table 3). Over-
coming these researcher–participant barriers is critical to 
developing appropriate preventative strategies and interven-
tions and understanding health-related risks in these vulner-
able populations.
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Table 3. Identified barriers to racial and ethnic minority participation in research and potential solutions.a
CLASSIFICATION PROBLEM POTENTIAL SOLUTION(S)
Researcher
lack of knowledge about 
cultural differences
given the historic lack of diversity of researchers and 
participants, the “gold standards” of research applies 
incorrect assumptions to ethnic minority populations; 
lack of knowledge about how to culturally and linguis-
tically adapt recruitment materials have been noted 
concerns
transparent communication; cultural sensitivity 
embodied throughout research process; consider 
community-based participatory research; elicit the 
support of trusted community leaders
lack of understanding in 
regards to true prevalence 
of disease and response 
to treatment in ethnic/
minority populations
extrapolation of outcome data from previously 
non-inclusive health studies (e.g. utilizing majority 
Caucasian population studies and generalizing it to 
non-Caucasian populations)
Carefully select trial sites based on geographic dis-
tribution of ethnic/racial minority patients and physi-
cians, keeping in mind the perceived prevalence of the 
disease in that region
Bias to research popula-
tion based on prior inter-
actions or experience
Failure to facilitate culturally sensitive and meaning-
ful discussions about informed consent to ensure 
truly informed choices
transparent communication with patient, family, and 
community based on cultural context; community 
engagement programs and health informational 
sessions
access to healthcare 
and treatment bias
Researcher’s poor understanding of patient’s 
needs and barriers to participation and retention in 
research trials
Culturally and contextually sensitive staff; attempt to 
alleviate socioeconomic barriers to participation (e.g., 
transportation or child care); giving patients access 
to trials within the convenience of their own homes 
reduces overhead costs and eliminates geographi-
cal barriers, transportation costs, and scheduling 
difficulties
Participant
Competing priorities Time and financial constraints related to the compet-
ing demands of working, needing to work, being the 
primary caretaker of children and or relatives, being 
the single head of household
Benefits to participation: mild monetary incentive, free 
lunch, or free health examination; addressing logistics 
that make participating in health research inconve-
nient: employer support to take time off to attend 
appointments, childcare, and transportation provisions
stigma stigma/judgment of disease because of participa-
tion in a study; privacy and confidentiality concerns 
related to the participant’s medical condition, 
personal health history, and genetics
support altruistic behavior, emphasizing contributions 
to family members and the community, while 
highlighting privacy safeguards
legal status/insurance Fear of deportation or adverse effects on immigration 
case; fear of discrimination from health insurance 
companies that may result from participating in 
health research
Reinforce privacy safeguards and highlight individual 
health benefits to research
Fear of unintended 
outcomes
the possible interference with current treatments or 
the lack of access to health care should injury or a 
new disease diagnosis arise
Make readily available information about individual 
health benefits and greater details about the study or 
clinical trial’s risks and safeguards
lack of access to 
information
Misperceived risk resulting from a lack of information 
regarding their health and risk of disease
Multiple modalities for health literacy promotions 
(in-person, community-focused, web-based, literary 
material, etc.)
Institutional
differences in health 
knowledge and practice
inability to recognize the signs and symptoms of dis-
ease, recognize the importance of treatment, readily 
seek or comply with treatment, and know or under-
stand treatment options or availability of clinical trials
Community-contextualization of education infor-
mation; community or racial/ethnically congruent 
research support staff
language barriers interpreter services unavailable; educational material 
not in native-language
having research staff representative of the research 
participants’ racial/ethnic group and demonstrate 
medical competencies
level of education lower educational level contributes to decreased 
understanding of healthcare
the availability of language-appropriate and 
education-level sensitive materials
Psychosocial
Mistrust and other 
attitudes
Poor perception of government facilities and ser-
vices; mistrust related to the fear of purposeful mis-
treatment and experimentation; being treated like a 
“lab rat” or “guinea pig”
Utilize studies that are perceived to have the least risk 
of discomfort or invasiveness, such as completing a 
survey or an education intervention
Perceived discrimination distrust of physicians and institutions inclusion of ethnically and racially diverse research 
staff; institutional culture of inclusion and diversity
Note: asummary inclusive of extrapolated themes from systematic review by george et al.17
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Breast and Cervical Cancer Research Challenges
Available breast cancer research. There is limited 
research in the literature focused solely on African-born 
immigrants and on their screening, treatment, outcomes, and 
follow-up for breast cancer. In a systematic review of the lit-
erature for African-born immigrants and breast cancer, only 
10 studies were identified.7 The research, a mix of quantitative 
and qualitative studies, focused on breast cancer prevention 
and detection, barriers to genetic testing, and barriers to mam-
mography screening. These studies, however, were limited by 
the size of the sample of African-born immigrants present 
in the study, homogeneity of the study group (e.g. focus on 
Somali women), and lack of consideration of diversity within 
African-born populations, such as religion or tribe, immigra-
tion status (refugee/asylee), and length of residency in the U.S.
In a study by Vahabi et al19 of breast cancer screening 
disparities among Canadian immigrants from several regions 
of the world including Africa, variables that were significantly 
associated with low rates of breast cancer screening for all or 
most regions included “living in low-income neighborhoods, 
being admitted as refugees, being new or recent immigrants, 
not having a general physical examination, not being enrolled 
in a physician enrollment model, having a male physician, 
and having an internationally trained physician”. Addition-
ally in this study, low rates of breast cancer screening were 
seen in new immigrants from sub-Saharan Africa (,5 years 
residence in new country) and recent immigrants (6–10 years 
residence in new country), and they were noted to be more 
likely to live in low-income neighborhoods, which coincides 
with low rates of screening in this demographic. In contrast, 
the study by Harcourt et al presented data that women who 
reside in the U.S. for a longer duration were more likely to be 
screened for breast and cervical cancer.20 Harcourt et al theo-
rized that women who have spent more time in the U.S. are 
more likely to be proficient in English and more acquainted 
with and have better skills in navigating the seemingly com-
plex U.S. health system.20 They are also likely to be differ-
ent in respect to cultural factors, including concerns related 
to modesty and cancer screening knowledge. This theory was 
born out of other studies looking at access to reproductive 
health services based on race and ethnicity.21
Available cervical cancer research. Despite the growing 
cancer burden in Africa, cervical cancer screening and preven-
tive measures such as HPV vaccination continue to receive low 
public health priority in the region, largely because of limited 
resources and other pressing public health concerns, including 
communicable diseases such as HIV, TB, and malaria. An esti-
mated 11.4% of women with normal cervical cytological find-
ings carry detectable HPV (Table 1), with higher prevalence in 
less-developed countries like Guinea (47.9%), Kenya (38.8%), 
Honduras (36.8%), and Mozambique (32.1%).8 As large 
numbers of the African population migrate west, those who 
are HPV carriers also remain at high risk for cervical cancer, 
despite their new environment due to barriers to health care.
As with breast cancer, research involving the African-
born immigrant population and cervical cancer are lack-
ing. A systematic review identified only 11 studies focusing 
on cervical cancer that included African-born immigrants 
in the study.7 Studies included cross-sectional analysis and 
some qualitative data, although only one study focused on 
interventions.7 In one of the reported studies conducted 
among foreign-born women, authors found disparities in 
cervical cancer screening based on length of stay in the U.S., 
with a higher percentage of immigrants residing longer in the 
U.S., having received screening in their lifetime as compared 
to recent immigrants; however, only a small population (2%) 
within the study were actually African-born immigrants. In 
the study by Harcourt et al, only 52% of African-immigrant 
women adhered to screening recommendations in the U.S., 
while screening rates for U.S.-born women surpassed 80%. 
This study’s limitation was defining the study population as 
Somali or “other African immigrants”, highlighting the lack 
of heterogeneity and diversity in study samples.20
Barriers to adhering to screening recommendations were 
similar to previously cited barriers such as language difficul-
ties, distrust of the interpreters, fear of the test (pain, lack of 
trust), negative past experiences, and competing priorities and 
cultural barriers.7
Discussion
The African-born immigrant population, inclusive of the refu-
gee and asylum-seeking cohort of this population, denotes one 
of the most vulnerable populations in the U.S.; yet, the under-
standing of their needs to access health care, particularly in 
cancer control, is insufficient as evident by the limited research 
available on this group. Studies that seek to focus on cancer 
control in black women typically combine data on African-born 
immigrants, U.S.-born blacks, and black Caribbean women, 
resulting in extrapolation of potentially misleading data and 
an application of these outcomes to this underresearched 
population. American-born “African-American” women in 
the U.S. have higher rates of mortality and higher percent-
ages of late-stage diagnoses of breast and cervical cancer when 
compared to other ethnic groups.22,23 Grouping foreign-born 
blacks with American-born blacks misses important varia-
tions within these populations and ignores potential cultural 
differences between the two populations that may have pro-
foundly different effects on health outcomes.
It is imperative that this population not be ignored, or 
grouped into categories, and it is equally important to sepa-
rate African-born immigrants based on region or country and 
include variables focused on diversity even within these groups, 
including immigration status and religion. Cultural differ-
ences addressed by studying diverse populations within the 
African-born population as a whole may lead to identification 
of differences in health-seeking behavior. Research is needed 
to further understand the factors that encourage or detract 
from screening recommendations, adherence to treatment, 
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and follow-up care related to cervical and breast malignancy. 
To date, there are no apparent studies that solely consider 
adherence to treatment following diagnosis, outcome data, 
and adherence to follow-up in this population, nor is there 
an abundance of researched intervention programs targeted to 
this population.
Achieving inclusive, meaningful research in this popu-
lation may best be accomplished through multi-institutional 
collaborations to ensure diversity among African-born popu-
lations, and further stratification may delineate risks, behav-
iors, and associations unique to specific subgroups within these 
populations. Engagement with community-based organiza-
tions that serve these communities may provide a platform for 
exploring meaningful interventions on health promotion and 
research in this underrepresented population.
Conclusion
Trends in immigration are not expected to change for this pop-
ulation and may even be expected to rise. The needs of African-
born immigrants, refugees, and asylum seekers should emerge 
as a new public health priority, given the inherent risk to the 
population based on their native countries, current cancer 
data and cancer trends, and the continued rise in this pop-
ulation in the U.S. This health-care inadequacy can only be 
addressed with increasing availability of critical data through 
research, education of researchers to be mindful of inherent 
differences in populations and to utilize cultural sensitivity 
in their research, and active involvement and empowerment 
of immigrant communities themselves. In doing so, we will 
widen our health-care safety net to be inclusive of one of the 
most at-risk populations in the world, increasing in size here 
in the U.S., and we will potentially decrease disease burden in 
this population.
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